Core Points - Orion Energy Systems, Inc. announced the authorization of equity awards for Michael Ontrop, the new Senior Vice President of Channel Sales, including 100,000 shares of restricted stock and a non-qualified stock option for 125,000 shares of Common Stock [1][2] - The equity awards were approved by Orion's Board of Directors as a material inducement for Mr. Ontrop to accept the employment offer, and the shares will not be drawn from the 2016 Omnibus Incentive Plan [2] - The restricted stock award will vest one-third on each of the first three anniversaries of the grant date, contingent on Mr. Ontrop's continued employment [3] - The stock option will vest based on the Company's share price reaching specified levels ($3.00, $4.00, and $5.00) over a three-year period, with the effective grant date set for July 18, 2025 [4] Company Overview - Orion Energy Systems specializes in energy efficiency and clean tech solutions, including LED lighting, EV charging solutions, and maintenance services [5] - The company focuses on turnkey design-through-installation solutions for large national customers and projects through ESCO and distribution partners, aiming to help customers achieve business and environmental goals [5] - Orion is committed to operating responsibly and emphasizes sustainability and governance in its operations [6]

Further reduction of outstanding debt by Madryn Asset Management improves the Company’s balance sheet positionTORONTO, July 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on June 30, 2025, the Company exchanged $6.5 million of its subordinated convertible notes held by affiliates of Madryn Asset Management, LP (“Madryn”) for 325,651 shares of its Series Y preferred stock. Following the tra ...

Group 1 - CareTrust REIT (NYSE: CTRE) is positioned favorably compared to other healthcare REITs that are experiencing a sectoral cool-off due to reduced funding for biotech and life sciences R&D [1] - The company focuses on senior and assisted living, which remains a stable segment within the healthcare real estate investment trust market [1]

More than 5 years of experience in equity analysis in LatAm. We provide our clients with in-depth research and insights to help them make informed investment decisions. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US ...

through again, that's President Trump making those comments on the white House lawn. >> Okay, let's get back to our guest. Joining us right now again, Andrew Turkey.He's the co-CEO of investing platform Republic Republic, announcing it launched a SpaceX token, of course, SpaceX owned by Elon Musk, which mirrors the performance of private shares of the company. Actually, you know what. Before we even go there, let me just ask you, since we've been watching this together.Sure. One of the big questions about, ...

Local oncology practice moves to expanded location to enhance cancer care for Collier County community NAPLES, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Health Parkway clinic in Naples to a larger suite at 15455 Collier Blvd., Suite 101, in the Lintree Medical Plaza. Current and prospective patients can call (239) 231-7258 for more information or to schedule an appointment. Board-certified medical oncolog ...

TD Cowen says Strategy’s equity-to-BTC loop justifies NAV premium despite risks, maintains buy rating https://t.co/9CiNavqwYD ...

Core Insights - Dividend yield is a key metric for identifying dividend stocks, reflecting the amount of a company's dividend as a percentage of its stock price, which can fluctuate daily [1] - A strong balance sheet, indicated by a low debt-to-equity ratio, is essential for long-term dividend sustainability [2][3] Company Summaries Costco - Costco has a dividend yield of 0.53% with an annual dividend of $5.20 and a 22-year track record of dividend increases [5] - The company has delivered a total return of over 266% over the past five years, with a debt-to-equity ratio of 0.21%, indicating strong financial health [6] - Investors should focus on the 12.7% average dividend growth over the last three years rather than the current yield [7] Archer-Daniels-Midland (ADM) - ADM boasts a dividend yield of 3.86% with an annual dividend of $2.04 and a 53-year history of dividend increases [8] - The company's debt-to-equity ratio stands at 0.34%, suggesting a stable dividend outlook [8] - However, ADM's growth is closely tied to commodity prices, which are cyclical, making it less defensive compared to consumer staples [9] Medtronic - Medtronic has a dividend yield of 3.26% with an annual dividend of $2.84 and a 49-year history of dividend increases [11] - The company is well-positioned in the aging population market and in AI and machine learning, with a debt-to-equity ratio of around 0.53% [12][13] - Despite its potential, Medtronic is not currently highlighted as a top buy by analysts, indicating some caution among investors [14]

Group 1 - Moretus Research provides high-quality equity research focused on U.S. public markets, aiming to deliver clarity, conviction, and alpha for serious investors [1] - The research framework identifies companies with durable business models, mispriced cash flow potential, and intelligent capital allocation, emphasizing a structured and repeatable approach [1] - Valuation methods are based on sector-relevant multiples tailored to each company's business model and capital structure, prioritizing comparability, simplicity, and relevance [1] Group 2 - Research coverage focuses on underappreciated companies experiencing structural changes or temporary dislocations, where disciplined analysis can yield asymmetric returns [1] - Moretus Research aims to elevate the standard for independent investment research by providing professional-grade insights and actionable valuation [1]

Analyst's Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Moretus Research delivers state-of-the-art, buy-side quality equity research for serious investors see ...